Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis.
Grundmann
Sonja A
SA
Hemfort
Pia B
PB
Luger
Thomas A
TA
Brehler
Randolf
R
D000368:Aged; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000628:therapy; D002908:Chronic Disease / Q000628:therapy; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D008279:Magnetic Resonance Imaging; D008297:Male; D000069444:Omalizumab; D011859:Radiography; D012220:Rhinitis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy; D012852:Sinusitis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy; D016896:Treatment Outcome
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E